Durect
在场
Durect 是一家在股票代码 DRRX (US) 下上市的公司。
高管
查看带有其 16 名主要高管的组织结构图
Durect 搜索最多的简介
- James Brown, President, Chief Executive Officer and Director
- Gail Maderis, Chairman of the Board
- Gail Farfel, Director
创建提醒
跟踪 Durect 的高管变动
药店
Durect 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- Cosette Pharmaceuticals has announced the acquisition of Mayne Pharma (公布2025二月25号).
- Bain Capital 已收购 Mitsubishi Tanabe Pharma (公布2025二月12号).
- Crown Laboratories 已收购 Revance Therapeutics (公布2025二月9号).
药店 行业的其他推荐联系人
消息
Durect 的最新新闻稿
- News | DURECT
- News Releases | DURECT Corporation
- DURECT | Media Kit
- DURECT Corporation to Present Additional Safety and Efficacy Signals from Phase 1b Clinical Trial of DUR-928 in NASH Patients at The Liver Meeting Digital Experience™ 2020 | DURECT Corporation
- DURECT Corporation to Participate in Fireside Chat at H.C. Wainwright 4th Annual NASH Investor Conference | DURECT Corporation
- DURECT Corporation Announces First Patient Dosed in Phase 2 Safety and Efficacy Study of DUR-928 in COVID-19 Patients with Acute Liver or Kidney Injury | DURECT Corporation
- DURECT Corporation Announces Design of Phase 2b AH Study (AHFIRM) | DURECT Corporation
- DURECT Corporation to Participate in September Virtual Investor Conferences | DURECT Corporation
- DURECT Corporation Announces Presentation of Phase 2a Pharmacokinetic Data of DUR-928 in Alcoholic Hepatitis at Digital International Liver Congress (EASL) | DURECT Corporation
- DURECT Corporation Fireside Chat hosted by Ellie Merle of Cantor Fitzgerald | DURECT Corporation
- View more press releases Close
